Determination of dosing guidelines for stavudine (2',3'-didehydro-3'-deoxythymidine) in children with human immunodeficiency virus infection

Determination of dosing guidelines for stavudine (2',3'-didehydro-3'-deoxythymidine) in children with human immunodeficiency virus infection

Item
http://www.wikidata.org/entity/Q33981606
LIPODYSTROPHY SYNDROME IN HIV-INFECTED CHILDREN ON HAART.A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand.Age-related differences in the pharmacokinetics of stavudine in 272 children from birth to 16 years: a population analysis.Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants.High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study.Estimation of intracellular concentration of stavudine triphosphate in HIV-infected children given a reduced dose of 0.5 milligrams per kilogram twice daily.Antiretroviral therapy during the neonatal period.
P2860

Determination of dosing guidelines for stavudine (2',3'-didehydro-3'-deoxythymidine) in children with human immunodeficiency virus infection

Item
http://www.wikidata.org/entity/Q33981606
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Determination of dosing guidel ...... munodeficiency virus infection
@ast
Determination of dosing guidel ...... munodeficiency virus infection
@en
type
label
Determination of dosing guidel ...... munodeficiency virus infection
@ast
Determination of dosing guidel ...... munodeficiency virus infection
@en
prefLabel
Determination of dosing guidel ...... munodeficiency virus infection
@ast
Determination of dosing guidel ...... munodeficiency virus infection
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Determination of dosing guidel ...... munodeficiency virus infection
@en
P2093
P2860
P304
P31
P356
10.1128/AAC.45.3.758-763.2001
P407
P433
P478
P577
P698
P932